Adamsbrown Wealth Consultants LLC Moderna, Inc. Transaction History

Adamsbrown Wealth Consultants LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$118.38 - $210.04 $138,622 - $245,956	1,171 New	1,171 $0
Q2 2022 Jul 27, 2022	SELL	$117.13 - $176.59 $298,095 - $449,421	-2,545 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $50,331 - $93,549	398 Added 18.54%	2,545 $438,000
Q4 2021 Feb 17, 2022	BUY	$225.82 - $368.51 $484,835 - $791,190	2,147 New	2,147 $545,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Adamsbrown Wealth Consultants LLC, based on Form 13F filings with the SEC.

Stay updated on Adamsbrown Wealth Consultants LLC with notifications on news.